245 related articles for article (PubMed ID: 26860770)
1. Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis.
Yang Y; Lin X; Lu X; Luo G; Zeng T; Tang J; Jiang F; Li L; Cui X; Huang W; Hou G; Chen X; Ouyang Q; Tang S; Sun H; Chen L; Gonzalez FJ; Wu M; Cong W; Chen L; Wang H
Gut; 2016 Jul; 65(7):1186-201. PubMed ID: 26860770
[TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
[TBL] [Abstract][Full Text] [Related]
6. Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis.
Chen PJ; Yeh SH; Liu WH; Lin CC; Huang HC; Chen CL; Chen DS; Chen PJ
Hepatology; 2012 Aug; 56(2):632-43. PubMed ID: 22392644
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPase and Wnt signaling pathways in hepatocarcinogenesis.
Lechel A; Rudolph KL
Gastroenterology; 2008 Mar; 134(3):875-8. PubMed ID: 18325396
[No Abstract] [Full Text] [Related]
8. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
[TBL] [Abstract][Full Text] [Related]
10. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
13. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
14. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
16. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
Kowalik MA; Guzzo G; Morandi A; Perra A; Menegon S; Masgras I; Trevisan E; Angioni MM; Fornari F; Quagliata L; Ledda-Columbano GM; Gramantieri L; Terracciano L; Giordano S; Chiarugi P; Rasola A; Columbano A
Oncotarget; 2016 May; 7(22):32375-93. PubMed ID: 27070090
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma.
Jia P; Wei G; Zhou C; Gao Q; Wu Y; Sun X; Li X
Technol Cancer Res Treat; 2018 Jan; 17():1533034618765221. PubMed ID: 29618288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
